Carl Sandén
11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
- Contribution to journal › Article
- 2017
-
Mark
Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
- Contribution to journal › Article
- 2016
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
- Contribution to journal › Article
-
Mark
Global binding pattern of the Wilms' tumor gene 1 (WT1) +17AA -KTS isoform in leukemic cells
(2016) American Association for Cancer Research (AACR) 107th Annual Meeting 2016 In Cancer Research 76(14 Suppl.).
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
The DEK oncoprotein is upregulated by multiple leukemia-associated fusion genes.
- Contribution to journal › Letter
-
Mark
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
- Contribution to journal › Article
-
Mark
The DEK oncoprotein and its emerging roles in gene regulation.
- Contribution to journal › Scientific review
- 2014
-
Mark
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
- Contribution to journal › Article
-
Mark
Molecular Mechanisms of the DEK Protein in Leukemia
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
- Contribution to journal › Article
